382 related articles for article (PubMed ID: 16417699)
41. Prenatal foetal diagnosis of partial trisomy 3q and monosomy 13p due to a maternal balanced rearrangement.
Pires A; Ramos L; Venâncio M; Rei AI; Castedo S; Saraiva J
Prenat Diagn; 2005 Apr; 25(4):292-5. PubMed ID: 15849779
[TBL] [Abstract][Full Text] [Related]
42. Abnormal Down's screening test associated with severe hyperemesis gravidarum.
Pradhan P; Mohajer M
J Obstet Gynaecol; 2002 Nov; 22(6):692. PubMed ID: 12554274
[No Abstract] [Full Text] [Related]
43. Biochemical screening for congenital defects.
Bahado-Singh RO; Sutton-Riley J
Obstet Gynecol Clin North Am; 2004 Dec; 31(4):857-72, xi. PubMed ID: 15550339
[TBL] [Abstract][Full Text] [Related]
44. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
Spencer K
Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
[No Abstract] [Full Text] [Related]
46. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
Huang T; Boucher K; Summers AM
Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
[TBL] [Abstract][Full Text] [Related]
47. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
[TBL] [Abstract][Full Text] [Related]
48. Multiple marker screening.
Dickerson VM
West J Med; 1994 Aug; 161(2):161. PubMed ID: 7524245
[No Abstract] [Full Text] [Related]
49. Maternal serum triple analyte screening in pregnancy.
Graves JC; Miller KE; Sellers AD
Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965
[TBL] [Abstract][Full Text] [Related]
50. [Tri-test: clinical considerations on 1784 cases].
Caserta D; Baldi M; Carta G; Moscarini M
Minerva Ginecol; 1998 Mar; 50(3):73-5. PubMed ID: 9595918
[TBL] [Abstract][Full Text] [Related]
51. Prenatal screening for Down's syndrome.
Gocze PM; Arany A; Freeman DA
N Engl J Med; 1992 Dec; 327(27):1951; author reply 1952-3. PubMed ID: 1280772
[No Abstract] [Full Text] [Related]
52. [Unusual behavior of serum markers in risk evaluation for trisomy 21].
Guibaud S; Boisson C; Chambon V; Simplot A
Ann Biol Clin (Paris); 1998; 56(4):439-44. PubMed ID: 9754279
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters.
Reynolds TM; Vranken G; Van Nueten J; Aldis J
Int J Clin Pract; 2008 May; 62(5):735-43. PubMed ID: 17590221
[TBL] [Abstract][Full Text] [Related]
54. [Comment on the contribution by Benz et al.: Serum screening for Down syndrome in women under 35 years of age with an age independent index].
Reynolds T; Pistorius K; Spencer K; John R
Z Geburtshilfe Neonatol; 1995; 199(3):128-9. PubMed ID: 7553259
[No Abstract] [Full Text] [Related]
55. Preliminary estimate for the second-trimester maternal serum screening detection rate of the 45,X karyotype using alpha-fetoprotein, unconjugated estriol and human chorionic gonadotropin.
Benn PA; Ying J
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):160-6. PubMed ID: 15280141
[TBL] [Abstract][Full Text] [Related]
56. Prenatal diagnosis and molecular cytogenetic analysis of partial monosomy 10q (10q25.3-->qter) and partial trisomy 18q (18q23-->qter) in a fetus associated with cystic hygroma and ambiguous genitalia.
Chen CP; Chern SR; Wang TH; Hsueh DW; Lee CC; Town DD; Wang W; Ko TM
Prenat Diagn; 2005 Jun; 25(6):492-6. PubMed ID: 15966044
[TBL] [Abstract][Full Text] [Related]
57. Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses?
Ghidini A; Spong CY; Grier RE; Walker CN; Pezzullo JC
Prenat Diagn; 1998 Feb; 18(2):123-6. PubMed ID: 9516012
[TBL] [Abstract][Full Text] [Related]
58. Fetal axillary cystic hygroma: a novel association with triple X syndrome.
Iskender C; Tarım E; Cok T; Yalcinkaya C; Kalaycı H; Sahin F
Birth Defects Res A Clin Mol Teratol; 2012 Nov; 94(11):955-7. PubMed ID: 23109196
[TBL] [Abstract][Full Text] [Related]
59. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
Hsu JJ; Hseih TT; Liou JD; Soong YK
J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053
[TBL] [Abstract][Full Text] [Related]
60. Median parameters for Down's syndrome screening should be calculated using a moving time-window method.
Reynolds TM; Aldis J
Ann Clin Biochem; 2008 Nov; 45(Pt 6):567-70. PubMed ID: 18768535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
